Feng FY - Search Results

1

[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].

Zhang P, Feng FY, Wu LY, Hu Y, Liu JW, Gao YJ, Guan XQ, Nan KJ, Suo AL, Wang XW, Zhang MH, Zhang WD, Li CW, Zhang Y, Zhao JB. Zhang P, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):230-4. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875614 Clinical Trial. Chinese.

2

[Primary central nervous system lymphoma: a report of 28 patients].

Hu Y, Feng FY, Shi YK, Zhou LQ, Gu DZ, Wang QL. Hu Y, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):375-8. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312352 Chinese.

3

[Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].

Wang XY, Feng FY, Song ST, Wang HQ, Zhang MH, Liu J, Liu XY, Xu LG, Zhang Y. Wang XY, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):373-6. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16117903 Clinical Trial. Chinese.

4

[Correlation between the expression of PCDGF in serum and the chemotherapeutic sensitivity in NSCLC].

Hu Y, Feng FY, Chen SJ, Gao YN, Xiao T, Liu YN. Hu Y, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):603-5. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17236555 Chinese.

5

[Expression of serum breast drug-resistance protein in predicting chemosensitivity of NSCLC].

Hu Y, Feng FY, Cheng SJ, Gao YN, Xiao T, Liu YN. Hu Y, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):750-2. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366786 Chinese.

6

[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].

Dong M, Feng FY, Zhang Y, Xie GR, Wang YJ, Liu JW, Song ST, Zhou QH, Ren J, Jiao SC, Li J, Wang XW, Chen Q, Wang ZH, Xu N, Feng JF. Dong M, et al. Among authors: feng jf, feng fy. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):215-20. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756940 Clinical Trial. Chinese.

7

[Multicenter phase II clinical trial of uroacitides injection in the treatment for advanced malignant tumors].

Li Q, Feng FY, Chen Q, Jiao SC, Li F, Wang HQ, Huang WX, Ling CQ, Li MZ, Ren J, Zhang Y, Qin FZ, Zhou MZ, Zhu RZ. Li Q, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):534-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19062723 Clinical Trial. Chinese.

8

[Primary non-Hodgkin lymphoma in the female genital system: a report of 28 cases].

Hu Y, Feng FY, Zhang P, Zhou LQ, Zhang WH, Wang QL. Hu Y, et al. Among authors: feng fy. Zhonghua Zhong Liu Za Zhi. 2003 Sep;25(5):486-9. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14575576 Chinese.

9

[Nausea disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by anticancer drugs].

Zhang P, Feng F, He Y, Li Y, Zhou M, Cheng G, Chen Y. Zhang P, et al. Zhonghua Zhong Liu Za Zhi. 2002 Sep;24(5):504-7. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12485511 Clinical Trial. Chinese.

10

[Phase III clinical study of a new anticancer drug atofluding].

Li Q, Feng FY, Han J, Sui GJ, Zhu YG, Zhang Y, Zhang ZH, Li L, Wang PH, Zhou MZ, Zhang YC. Li Q, et al. Among authors: feng fy. Ai Zheng. 2002 Dec;21(12):1350-3. Ai Zheng. 2002. PMID: 12520746 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters